The antibody targets histone H2B, a core histone protein (14–15 kDa), specifically recognizing acetylation at lysine 20 (H2BK20ac). This modification is associated with transcriptional activation, DNA replication, and chromatin accessibility. The antibody exhibits no cross-reactivity with unacetylated H2B or other lysine residues, ensuring high specificity .
This antibody is validated for:
| Application | Dilution Range |
|---|---|
| WB | 1:500–1:2000 . |
| IF/ICC | 1:200–1:800 . |
| Dot Blot | 1:10–1:100 . |
| ELISA | Optimized for histone extracts (protocol available) . |
Acetylation at H2BK20 is linked to:
DNA replication: Facilitates chromatin decondensation during replication fork progression .
Cancer biology: Altered H2BK20ac levels correlate with tumor progression and therapeutic resistance .
Gene regulation: Associates with active transcription (e.g., enhancer regions) and histone chaperone interactions .
All data are derived from peer-reviewed validation studies and product specifications:
Acetyl-Histone H2B (Lys20) refers to the histone H2B protein that has been post-translationally modified through acetylation at the lysine 20 residue. This modification plays a crucial role in epigenetic regulation of gene expression.
Recent research has established histone H2B N-terminus multisite lysine acetylation (H2BNTac), including acetylation at Lys20, as a signature of active enhancers. H2BNTac prominently marks candidate active enhancers and a subset of promoters, discriminating them from ubiquitously active promoters . The acetylation neutralizes the positive charge of lysine residues, reducing electrostatic interactions with negatively charged DNA, which affects chromatin structure and accessibility to transcription factors.
Unlike some other histone marks, H2B Lys20 acetylation has been shown to specifically predict enhancer strength and outperform current models in predicting CBP/p300 target genes . This makes it particularly valuable for researchers studying gene regulation mechanisms and enhancer-promoter interactions.
Acetyl-Histone H2B (Lys20) antibodies can be utilized in multiple research applications:
These applications allow researchers to investigate the presence, localization, and dynamics of H2B Lys20 acetylation in various experimental contexts. For example, HeLa cells treated with sodium butyrate have been successfully used to demonstrate the specificity of anti-Acetyl-Histone H2B (Lys20) antibodies in both Western blot and immunocytochemistry applications .
Acetyl-Histone H2B (Lys20) antibodies are highly specific for histone H2B acetylated at Lysine 20 (K20ac). Quality antibodies show no cross-reactivity with non-modified Lysine 20 or other acetylated lysines in histone H2B .
Validation methods for these antibodies typically include:
Peptide array assays: These confirm specificity against known modifications across all histone proteins in a single experiment. This method tests the effects of neighboring modifications on the antibody's ability to detect a single modification site .
Western blotting with controls: Using acid extracts from cells treated with and without histone deacetylase inhibitors (HDACi) like sodium butyrate. For example, Western blot analysis of acid extracts from HeLa cells treated (+) or untreated (-) with sodium butyrate demonstrates the specificity of RM235 clone at 0.5 μg/mL .
Immunocytochemistry: Visualizing the nuclear localization pattern in cells with and without HDACi treatment. Immunocytochemical staining of HeLa cells treated with sodium butyrate using anti-Acetyl-Histone H2B (Lys20) antibodies shows specific nuclear staining patterns .
Dot blot assays: Testing antibody reactivity against synthetic peptides representing various histone modifications.
Researchers should verify that their chosen antibody has undergone rigorous validation to ensure experimental results are reliable and specific to the H2B Lys20 acetylation mark.
Proper storage and handling of Acetyl-Histone H2B (Lys20) antibodies are crucial for maintaining their performance and specificity:
For optimal experimental results:
Always centrifuge antibody vials briefly before opening
Keep antibodies on ice when in use
Return to appropriate storage conditions immediately after use
Follow manufacturer's recommendations for specific formulations
Proper handling ensures antibody stability and consistent performance across experiments, reducing variability in your research results.
Optimal dilutions vary depending on the specific application, antibody format, and experiment conditions:
| Application | Recommended Dilution Range |
|---|---|
| Western Blot (WB) | 1:500-1:2000 or 0.5-2 μg/mL |
| Immunofluorescence (IF)/ICC | 1:200-1:800 or 1-2 μg/mL |
| DOT BLOT | 1:10-1:100 |
| ELISA | 0.2-1 μg/mL |
| Multiplex assays | 0.1-0.5 μg/mL |
It's important to note that:
These recommendations provide starting points for assay optimization
The actual working concentration should be determined by the researcher through titration experiments
Sample-dependent variations may require adjustment of dilutions
For some antibodies, validation data galleries may provide additional guidance on optimal dilutions for specific sample types
It is strongly recommended that each reagent be titrated in each testing system to obtain optimal results
Performing optimization experiments with positive controls (e.g., HeLa cells or NIH/3T3 cells treated with histone deacetylase inhibitors like sodium butyrate or trichostatin A) can help determine the ideal dilution for your specific experimental setup.
H2B Lys20 acetylation plays significant roles in gene regulation through several mechanisms:
Enhancer marking: H2B N-terminus multisite lysine acetylation (H2BNTac), including Lys20, distinctively marks active enhancers and discriminates them from other candidate cis-regulatory elements. This allows for improved prediction of enhancer strength and identification of target genes .
Conformational dynamics: Acetylation of H2B tails, including at Lys20, changes their conformational space and interaction with DNA. All-atomistic molecular dynamics simulations demonstrate that:
DNA accessibility: H2B acetylation may increase DNA accessibility for regulatory proteins to bind, aiding in gene regulation and nucleosome core particle stability . The effects include:
A comprehensive analysis of effects on H2B N-terminal tails upon acetylation shows:
| Analysis | Effects on H2B N-terminal tails upon acetylation |
|---|---|
| Radius of gyration (Rg) | With acetylation, the Rg of the H2B tails compared to wild type increases |
| Secondary structure propensity | With acetylation, tail-1 helix and β-sheet propensity increases; the H2B tail-2 helix propensity also increases |
| DNA–tail contacts | Number of contacts reduces upon acetylation compared to wild type for both H2B tails |
| Binding free energy | Binding free energy weakens upon acetylation compared to wild type for both H2B tails |
These structural and functional changes demonstrate the critical role of H2B Lys20 acetylation in gene regulation mechanisms .
H2B Lys20 acetylation has recently emerged as a significant marker of active enhancers with specific characteristics:
Enhancer signature: H2B N-terminus multisite lysine acetylation (H2BNTac), including Lys20 acetylation, prominently marks candidate active enhancers and a subset of promoters. It distinctively discriminates them from ubiquitously active promoters .
Validation rate: H2BNTac-positive candidate enhancers show a high validation rate in orthogonal enhancer activity assays. Research has demonstrated that a vast majority of endogenously active enhancers are marked by H2BNTac alongside H3K27ac .
Predictive power: H2BNTac intensity predicts enhancer strength and outperforms current state-of-the-art models in predicting CBP/p300 target genes, making it a valuable marker for enhancer research .
Mechanistic specificity: Two key mechanisms underlie the distinctive H2BNTac specificity:
Validation studies: Using MPRA- and eRNA-defined candidate enhancers, researchers have demonstrated a high validation rate of H2BNTac+ enhancers. Virtually all highly acetylated regions are actively transcribed, with validation rates correlating with acetylation levels .
These findings have broad implications for generating fine-grained enhancer maps and modeling CBP/p300-dependent gene regulation, positioning H2B Lys20 acetylation as a key epigenetic marker for researchers studying enhancer biology and transcriptional regulation.
Acetylation of H2B Lys20 induces significant changes in nucleosome structure and dynamics, as revealed by molecular dynamics simulations and experimental studies:
Charge neutralization effects: Acetylation neutralizes the positive charge of lysine residues, reducing electrostatic interactions:
Structural rearrangements: Addition of acetyl groups alters the physical properties of H2B tails:
DNA-histone interactions: Acetylation modifies how H2B tails interact with DNA:
Reduced number of contacts between DNA and H2B tails
Shift in hydrogen bond interactions away from specific regions of the tail
Reduced binding free energy between acetylated tails and DNA compared to wild-type
Changes in tail interactions with specific superhelical locations (SHL) on nucleosomal DNA
Conformational dynamics: Principal component analysis (PCA) reveals:
These structural changes ultimately contribute to increased DNA accessibility, potentially allowing regulatory proteins to bind more readily to DNA. This mechanism helps explain how H2B Lys20 acetylation contributes to gene regulation and nucleosome stability in the context of transcriptional activation and enhancer function .
Detection of H2B Lys20 acetylation requires selecting appropriate methods based on your experimental goals:
Best for: Quantifying global levels of H2B Lys20 acetylation
Protocol highlights:
Best for: Visualizing nuclear localization and distribution patterns
Protocol highlights:
Best for: Genome-wide mapping of H2B Lys20 acetylation patterns
Protocol highlights:
Best for: High-throughput quantitative screening
Protocol highlights:
Best for: Quick screening of multiple samples
Protocol highlights:
For all methods, including appropriate controls is essential:
Positive controls: cells treated with HDACi (sodium butyrate or trichostatin A)
Negative controls: non-specific IgG and untreated cells
Peptide competition assays to confirm specificity
The choice of method should align with your research question, with ChIP-seq being particularly valuable for enhancer studies and Western blotting for global quantification of acetylation levels.
Histone deacetylase inhibitors (HDACi) like sodium butyrate and trichostatin A are powerful tools for studying H2B Lys20 acetylation:
Enzyme inhibition: HDACi block the activity of histone deacetylases (HDACs), enzymes that remove acetyl groups from histones
Acetylation accumulation: This blockage leads to increased histone acetylation levels, including at H2B Lys20
Global vs. site-specific effects: While HDACi increase global acetylation, the magnitude of increase varies between different histone residues
Positive controls: Trichostatin A-treated NIH/3T3 cells and sodium butyrate-treated HeLa cells serve as excellent positive controls for H2B Lys20ac antibody validation
Western blot detection: Clear differences in H2B Lys20ac levels are observable between treated and untreated cells
Immunocytochemistry: Enhanced nuclear staining is evident in treated cells compared to untreated controls
Western blot analysis of acid extracts from HeLa cells shows significantly increased H2B Lys20 acetylation after sodium butyrate treatment
Immunocytochemical staining of sodium butyrate-treated HeLa cells reveals distinct nuclear patterns of H2B Lys20 acetylation
Trichostatin A treatment of NIH/3T3 cells produces detectable levels of H2B Lys20 acetylation for Western blot applications
Treatment concentrations and durations should be optimized for each cell type
Typical sodium butyrate concentrations range from 5-10 mM for 4-24 hours
Trichostatin A is typically used at lower concentrations (50-500 nM) for similar durations
Cell type-specific responses may vary in magnitude and kinetics
Combined treatment with transcriptional activators may yield synergistic effects
HDACi treatment provides a reliable method for generating positive controls in H2B Lys20ac studies and offers insights into the dynamic regulation of this important epigenetic mark.
CBP/p300 (CREB-binding protein/E1A binding protein p300) plays a crucial and specific role in H2B Lys20 acetylation and enhancer regulation:
Selective catalysis: Unlike H3K27ac, which can be catalyzed by multiple histone acetyltransferases, H2B N-terminus multisite lysine acetylation (H2BNTac), including Lys20, is specifically catalyzed by CBP/p300
Mechanistic distinction: This enzymatic specificity is one of the two key mechanisms that underlie the distinctive H2BNTac specificity in marking enhancers
Target prediction: H2BNTac intensity outperforms current state-of-the-art models in predicting CBP/p300 target genes
Enhancer strength: The level of H2BNTac correlates with enhancer activity, making it a valuable predictor of enhancer strength
Gene expression correlation: CBP/p300-dependent acetylation of H2B creates a signature that helps identify which genes are regulated by specific enhancers
Experimental validation: H2BNTac-positive candidate enhancers show high validation rates in orthogonal enhancer activity assays
Active enhancer marking: The vast majority of endogenously active enhancers are marked by H2BNTac alongside H3K27ac
Enhancer discrimination: H2BNTac prominently marks candidate active enhancers and a subset of promoters, discriminating them from ubiquitously active promoters
Inhibiting CBP/p300 with specific inhibitors can help validate the role of these enzymes in H2B Lys20 acetylation
ChIP-seq for CBP/p300 binding sites alongside H2BNTac mapping provides complementary data for enhancer identification
The specificity of the CBP/p300-H2BNTac relationship makes it particularly valuable for modeling enhancer-dependent gene regulation
Understanding the specific relationship between CBP/p300 and H2B Lys20 acetylation has broad implications for generating fine-grained enhancer maps and modeling gene regulation mechanisms in both normal cellular processes and disease states.
H2B Lys20 acetylation and H3K27 acetylation show both overlapping and distinct properties in marking regulatory elements:
Enzymatic specificity:
Histone dynamics:
Regulatory element marking:
Enhancer prediction:
Validation rates:
Combined analysis:
For enhancer identification, H2BNTac provides higher specificity for active enhancers
H3K27ac remains valuable as a broadly-used marker with extensive existing datasets
Combining both marks can improve discrimination between enhancers and promoters
Different antibody characteristics may affect detection sensitivity for each mark
The distinct properties of H2B Lys20 acetylation make it a valuable complementary or alternative mark to H3K27ac for researchers studying enhancer biology and gene regulation mechanisms, potentially offering improved specificity in identifying active enhancers versus other regulatory elements.
Researchers face several technical and biological challenges when validating H2B Lys20 acetylation patterns:
Antibody specificity:
Signal detection:
Low abundance of specific acetylation marks requiring sensitive detection methods
Background signal from non-specific antibody binding
Optimization of extraction methods for preserving acetylation marks
ChIP-seq challenges:
Dynamic nature of acetylation:
Rapid turnover of acetylation marks requiring time-course studies
Cell cycle-dependent variations in acetylation patterns
Rapid responses to cellular stimuli changing acetylation states
Cell type specificity:
Variation in H2BNTac patterns across different cell types
Need for appropriate positive controls for each experimental system
Differences in histone variant expression between cell types
Context-dependent function:
Differentiating the roles of H2B Lys20 acetylation at enhancers versus promoters
Understanding the interplay with other histone modifications
Determining causal relationships versus correlative associations
Multiple detection methods:
Appropriate controls:
Integrative approaches:
Combining H2BNTac with H3K27ac data for more robust enhancer identification
Correlating acetylation patterns with transcription factor binding
Functional validation through enhancer manipulation (e.g., CRISPR-based approaches)
Addressing these challenges requires careful experimental design, appropriate controls, and integration of multiple approaches to confidently validate H2B Lys20 acetylation patterns and their functional significance.
H2B Lys20 acetylation provides powerful predictive capabilities for enhancer functionality and target gene identification:
Correlation with activity:
Validation methods:
Quantitative relationship:
Improved accuracy:
Methodological approaches:
Correlating H2BNTac-marked enhancers with nearby gene expression
Integrating with chromosome conformation capture data (Hi-C, 4C, etc.)
Using with CBP/p300 binding data for comprehensive regulatory maps
Functional validation:
CRISPR interference/activation at H2BNTac-marked enhancers to validate target gene relationships
Comparing expression changes upon enhancer manipulation
Time-course studies to establish cause-effect relationships
Analytical pipeline:
ChIP-seq for H2BNTac to identify candidate enhancers
Quantification of acetylation signal intensity at each region
Integration with gene expression data from matching cell types
Correlation analysis to predict enhancer-gene relationships
Considerations for accuracy:
Cell type-specific patterns require matched ChIP-seq and expression data
Depth of sequencing affects detection of weakly acetylated regions
Combined with other enhancer marks (H3K27ac, H3K4me1) for robust prediction
The ability of H2B Lys20 acetylation to predict enhancer strength and target genes makes it a valuable tool for researchers studying gene regulation, potentially improving the accuracy of enhancer maps and regulatory network models beyond what was possible with traditional enhancer marks alone.
Molecular dynamics (MD) simulations provide detailed mechanistic insights into how H2B Lys20 acetylation affects nucleosome structure and function:
Conformational changes:
Secondary structure alterations:
DNA-histone interactions:
Charge neutralization effects:
"As charge neutralization occurs upon acetylation, the electrostatic repulsion between positively charged groups decreases in the tail"
This leads to decreased distance between charged residues in the acetylated tails
Reduced positive charge weakens interactions with negatively charged DNA phosphate backbone
Structural consequences:
Functional implications:
Simulation approaches:
Analysis techniques: